Browsing by Author Boyer, Michael

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 84  next >
Issue DateTitleAuthor(s)Citation
2008Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancerBoyer, Michael; Clifford, A.R.; Fulham, Michael; Gao, K; Hughes, Ceri; Jackson, Michael; Martin, Richard; Milross, Christopher; O'Brien, Christopher; Shannon, Kerwin; Tin, Mo Mo; Central Clinical School: Medicine; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Melanoma Foundation; Central Clinical School: Medicine; Central Clinical School: Surgery; Medicine; Central Clinical School: MedicineAccuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer, Head and Neck, vol.31, 2, 2008,pp 244-250
2002Adjuvant mitoxantrone chemotherapy for men at high risk of relapse following radical prostatectomy: a pilot studyBoyer, Michael; Stockler, Martin; Eisinger, D; Goad, J; Rosenthal, M; Webb, D; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant mitoxantrone chemotherapy for men at high risk of relapse following radical prostatectomy: a pilot study, UroOncology, vol.2,(1),2002,pp 15-17
2015Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsBoyer, Michael; Bennouna, Jaafar; Feng, Jifeng; Geater, Sarayut; Gorbunova, Vera; Hirsh, Vera; Hu, Cheng-Ping; Huang, Yunchao; Kato, Terufumi; Lee, Ki Hyeong; Lee, Kye Young; Lu, Shun; Massey, Dan; Mok, Tony; O'Byrne, Kenneth; Orlov, Sergey; Popat, Sanjay; Schuler, Martin; Sebastian, Martin; Sequist, Lecia; Shahidi, Mehdi; Su, Wu-Chou; Tsai, Chun-Ming; Wu, Yi-long; Yamamoto, Nobuyuki; Yang, James Chic-Hsin; Zazulina, Victoria; Zhou, Caicun; Central Clinical School: MedicineAfatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials, Lancet Oncology, vol.16, 2, 2015,pp 141-151
2016Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trialBoyer, Michael; et al, Various; Hirsh, Vera; Lee, Ki Hyeong; Lu, Shun; Mok, Tony; O'Byrne, Ken J; Park, Keunchil; Tan, Eng Huat; Yang, James Chic-Hsin; Zhang, Li; Central Clinical School: MedicineAfatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial, The Lancet Oncology, vol.17, 5, 2016,pp 577-589
2017Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trialBoyer, Michael; et al, Various; Hirsh, Vera; Lee, Ki Hyeong; Lu, Shun; Mok, Tony; O'Byrne, Kenneth J.; Paz-Ares, Luis; Tan, Eng Huat; Yang, James Chic-Hsin; Zhang, Li; Central Clinical School: MedicineAfatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial, Annals of Oncology, vol.28, 2, 2017,pp 270-277
2013Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancerBlinman, Prunella; Boyer, Michael; McCaughan, G; Stockler, Martin; School of Public Health: Public Health; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreBetter estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer, Internal Medicine Journal, vol.43, 4, 2013,pp 424-429
2004Cancer Consultation Preparation Package: Changing Patients But Not Physicians Is Not Enough.Boyer, Michael; Butow, Phyllis; Jackson, Michael; Pendlebury, Susan; Tattersall, Martin; Fung, Caroline; Central Clinical School: Medicine; Psychology; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicineCancer Consultation Preparation Package: Changing Patients But Not Physicians Is Not Enough., Journal of Clinical Oncology, vol.22,(21),2004,pp 4401-4409
2014Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Castillo, Lesley; Chiam, K; Clark, Susan J.; Daly, R; Lee, B Y; Lin, H-M; Mallesara, G; Nguyen, Q; Swarbrick, A.; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreCirculating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer, British Journal of Cancer, vol.110, 10, 2014,pp 2462-2471
2016Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancerBoyer, Michael; Clarke, Stephen; Kao, Steven; Pavlakis, Nick; Reid, Glen; van Zandwijk, Nico; Brahmbhatt, Himanshu; MacDiarmid, Jennifer; Central Clinical School: Medicine; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Northern Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteClinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer, Epigenomics, vol.8, 8, 2016,pp 1079-1085
2010Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized TrialBoland, Amy L.; Boyer, Michael; Gebski, Val; Grimison, Peter; Gurney, Howard; Simes, Robert John; Stockler, Martin; Craft, Paul; Harvey, V; Levi, John; Lewis, Craig; Olver, Ian N; Thomson, Damien; Toner, Guy C.; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreComparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial, Journal of the National Cancer Institute, vol.102, 16, 2010,pp 1253-1262
2002Current management of lung cancerBoyer, Michael; Clarke, Sarah; Central Clinical School: Medicine; SCA Academic ProgramsCurrent management of lung cancer, Current Therapeutics, vol.43/44,(12/1),2002,pp 49-54
2015Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerBoyer, Michael; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Breit, Samuel; Brown, David; Castillo, Lesley; Chatfield, Mark; Chiam, K; Daly, R; Henshall, Susan; Lee, B Y; Lee-Ng, K K Michelle; Lin, H-M; Molloy, Mark; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreCytokine profiling of docetaxel-resistant castration-resistant prostate cancer, British Journal of Cancer, vol.112, 8, 2015,pp 1340-1348
2016Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trialsBoyer, Michael; Janne, P. A.; Liang, Jane Q.; Mok, T. S. K.; O'Byrne, Kenneth; Paz-Ares, Luis; Ramalingam, Suresh; Sbar, E. I.; Taylor, I.; Zhang, H.; Central Clinical School: MedicineDacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials, Annals of Oncology, vol.27, 3, 2016,pp 423-429
2006Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.Beale, Philip; Boyer, Michael; Clarke, Stephen; Simes, Robert John; Stockler, Martin; Tattersall, Martin; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineDisarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer., British Journal of Cancer, vol.94,(2),2006,pp 208-212
2018Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trialsBeith, Jane; Boyer, Michael; Kao, Steven; McNeil, Catriona; Prasanna, Thiru; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineDose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials, Asia-Pacific Journal of Clinical Oncology, vol.14, 3, 2018,pp 125-133
2003Doxetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patientsBoyer, Michael; Clarke, Simon; Bishop, J F; Goh, B-C; Lehnert, M; McNeil, E; Millward, M J; Rischin, D.; Wong, J; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium InstituteDoxetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients, Annals of Oncology, vol.14,(3),2003,pp 449-454
2009Duration of Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized TrialsAskie, Lisa; Boyer, Michael; Soon, Yu Yang; Stockler, Martin; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: The Sydney Cancer Centre; School of Public Health: NH&MRC Clinical Trials CentreDuration of Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials, Journal of Clinical Oncology, vol.27,(20),2009,pp 3277-3283
2014Early Contact with Palliative Care Services: A Randomized Trial in Patients with Newly Detected Incurable Metastatic CancerBoyer, Michael; Butow, Phyllis; Hastings, Lucy; Jansen, Jesse; Martin, Andrew; Stockler, Martin; Tattersall, Martin; Devine, Rhonda; Glare, Paul; Ryan, Joan; Central Clinical School: Medicine; Psychology; Central Clinical School: Medicine; School of Public Health: Screening & Test Evaluation Program; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: MedicineEarly Contact with Palliative Care Services: A Randomized Trial in Patients with Newly Detected Incurable Metastatic Cancer, Journal of Palliative Care & Medicine, vol.4, 1, 2014,pp 1-6
2012Efficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST studyBoyer, Michael; Pavlakis, Nick; Abell, Fiona; de Souza, Paul; Horwood, Keith; Johnston, Michael; Millward, Michael; Rischin, Danny; Stein, Brian; Central Clinical School: Medicine; Northern Clinical School: MedicineEfficacy of erlotinib in patients with advanced Non-small-cell Lung Cancer (NSCLC): Analysis of the Australian subpopulation of the TRUST study, Asia Pacific Journal of Clinical Oncology, vol.8, 3, 2012,pp 248-254
2006Efficacy of patupilone in advanced local or metastatic gastric cancer: A phase IIa trialBoyer, Michael; Williams, Katrina; Ducreux, M.; Hsin, K. W.; Johri, A.; Liu, M.; Soo, R.; Yeo, W; Central Clinical School: Medicine; Children's Hospital Westmead: Paediatrics & Child HealthEfficacy of patupilone in advanced local or metastatic gastric cancer: A phase IIa trial, Journal of Clinical Oncology, vol.24,(18S),2006,pp 195 (Abstract 4069)-195